US Supreme Court Decision Strengthens Bayer's Argument in Roundup Litigation

US Supreme Court Decision Strengthens Bayer’s Argument in Roundup Litigation

**US Supreme Court Affirms Bayer-Monsanto in Glyphosate Lawsuit, Affecting Thousands of Cases** In a notable legal triumph for Bayer-Monsanto, the US Supreme Court has affirmed the company’s position that federal pesticide legislation overrides state regulations mandating cancer warnings on the labels of its glyphosate-containing herbicide, Roundup. This ruling influences more than 60,000 active lawsuits from […]

Read More
Trump Administration Supports Contentious OMB Initiative Despite Growing Dissent

Trump Administration Supports Contentious OMB Initiative Despite Growing Dissent

**U.S. Research Community Confronts Uncertainty Due to Contentious OMB Regulation** A suggested regulation from the White House Office of Management and Budget (OMB) that could empower political appointees with control over federal research grant allocations is encountering considerable opposition from the U.S. research and advocacy sectors. This regulation, set to take effect on October 1, […]

Read More
A Man Recording His Reflections and Encounters via a Blog

A Man Recording His Reflections and Encounters via a Blog

Certainly, here’s an article generated based on the topic you provided: — ### The Path of an Autodidactic Historian of Science and Mathematics In today’s digital landscape, debating historical assertions frequently takes place on social media, where facts can often be overshadowed by personal interpretation. A closer inspection reveals that some seemingly casual commentators possess […]

Read More
Promoting Genetic Medicine

Promoting Genetic Medicine

‘We are now effectively reshaping these highly intriguing DNA-targeting technologies into something that resembles a therapeutic much more,’ states Benjamin Oakes, CEO of Scribe Therapeutics – a genetic medicine company based in the US that is customizing Crispr editing technology to create both genetic and epigenetic therapies. Oakes co-established Scribe in 2017 with three former […]

Read More